Cargando…

Non-culprit lesion percutaneous coronary intervention during acute myocardial infarction – the road not taken?

Detalles Bibliográficos
Autores principales:	Witberg, Guy, Kornowski, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495120/ https://www.ncbi.nlm.nih.gov/pubmed/26161096 http://dx.doi.org/10.5114/pwki.2015.52277

Ejemplares similares

Optimal Timing of Coronary Intervention in Non-Culprit Lesion in ST Elevation Myocardial Infarction with Multi-Vessel Disease
por: Seo, Jongkwon, et al.
Publicado: (2020)

Renal functions and prognosis in acute myocardial infarction. Concomitant left ventricular dysfunction should have been taken into account
por: Okyay, Kaan
Publicado: (2018)

The independent impact of dementia in patients undergoing percutaneous coronary intervention for acute myocardial infarction
por: Kodesh, Afek, et al.
Publicado: (2023)

Angioscopic Evaluation of Thrombi in the Culprit Coronary Lesions in Patients With Acute Myocardial Infarction
por: Morio, H., et al.
Publicado: (2000)

The clinical prediction factors for non-culprit lesion progression in patients with acute ST elevation myocardial infarction after primary percutaneous coronary intervention
por: Wang, Jian, et al.
Publicado: (2022)

Independent Impact of Peripheral Artery Disease on Percutaneous Coronary Intervention
por: Perl, Leor, et al.
Publicado: (2020)

Percutaneous Intervention in ST-Elevation Myocardial Infarction: Culprit-only or Complete Revascularization?
por: Osório, Ana Paula Susin, et al.
Publicado: (2017)

T-cells in myocardial infarction: Culprit instigators or mere effectors?
por: Liberale, Luca, et al.
Publicado: (2018)

Treat or Not to Treat Non-culprit Coronary Artery with Significant Stenosis during Primary Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2018)

Acute myocardial infarction in the elderly
por: Zijlstra, F., et al.
Publicado: (2015)

Identification of Coronary Culprit Lesion in ST Elevation Myocardial Infarction by Using Deep Learning
Publicado: (2022)

Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination
por: Kornowski, Ran, et al.
Publicado: (2022)

Percutaneous coronary intervention without surgery on‐site is here to stay
por: de Winter, R. J.
Publicado: (2013)

Assessment of validity of the ‘Culprit Score’ for predicting the culprit lesion in patients with acute inferior wall myocardial infarction
por: Mohanty, Abhisekh, et al.
Publicado: (2016)

Factors associated with difficulty in crossing the culprit lesion of acute myocardial infarction
por: Ishibashi, Shun, et al.
Publicado: (2021)

Is Hospital Percutaneous Coronary Intervention Volume-In-hospital Outcome Relation an Issue in Acute Myocardial Infarction?
por: Rha, Seung-Woon
Publicado: (2020)

Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease
por: Witberg, Guy, et al.
Publicado: (2019)

Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction
por: Hussain, Muhammad, et al.
Publicado: (2020)

Acute and spontaneous coronary thrombosis in non-culprit artery during percutaneous coronary intervention in myocardial infarction with ST-segment elevation: A “shocking” case
por: Buccheri, Dario, et al.
Publicado: (2015)

Prognostic impact of pre-interventional culprit artery thrombolysis in myocardial infarction (TIMI) flow in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention
por: Shaaban, Raouf, et al.
Publicado: (2022)

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
por: Wu, Jing, et al.
Publicado: (2022)

The Road Not Taken: Commensal or Virulent Pathogen
Publicado: (2020)

Immediate percutaneous coronary intervention in NSTE-ACS: the sun is not hurried by early risers
por: Knaapen, P.
Publicado: (2016)

Distal Protection During Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction
por: Ishihara, Masaharu
Publicado: (2016)

Predictors of recurrent acute myocardial infarction despite initially successful percutaneous coronary intervention: back to the basic
por: Choi, Seonghoon
Publicado: (2022)

New Predictors of Early and Late Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction and Unprotected Left Main Coronary Artery Culprit Lesion
por: Homorodean, Cãlin, et al.
Publicado: (2019)

Percutaneous Atrio-Ventricular Valve Interventions: Contemporary Advances and Remaining Challenges
por: Perl, Leor, et al.
Publicado: (2022)

Homocysteine is associated with the progression of non-culprit coronary lesions in elderly acute coronary syndrome patients after percutaneous coronary intervention
por: Han, Tian-Wen, et al.
Publicado: (2016)

Citius, Altius, Fortius: The impact of guide catheter extensions in contemporary percutaneous coronary intervention
por: Christakopoulos, Georgios E., et al.
Publicado: (2016)

Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Zhang, Dongfeng, et al.
Publicado: (2014)

Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction
por: Lang, Jiachun, et al.
Publicado: (2022)

Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes
por: Cui, Kongyong, et al.
Publicado: (2019)

Pathologists in pursuit of the COVID-19 culprit
por: Yi, Eunhee S, et al.
Publicado: (2020)

Prognosis of cardiogenic shock secondary to culprit left main coronary artery lesion‐related myocardial infarction
por: Galván‐Román, Francisco, et al.
Publicado: (2022)

The road not taken: beyond our embarrassment and skepticism
por: Choi, Jeom-Il
Publicado: (2019)

The simpler, the better: culprit-only intervention is beneficial in patients with chronic kidney disease with concurrent acute myocardial infarction and multivessel disease
por: Jo, Sang-Ho
Publicado: (2015)

Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction
por: Carrick, David, et al.
Publicado: (2016)

Renal Failure Impact on the Outcomes of ST-Segment Elevation Myocardial Infarction Patients Due to a Left Main Coronary Culprit Lesion Treated Using a Primary Percutaneous Coronary Intervention
por: Homorodean, Cãlin, et al.
Publicado: (2019)

Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study
por: Ibrahim, Homam, et al.
Publicado: (2017)

Molecular imaging of coronary atherosclerosis; predictive of an acute myocardial infarction?
por: van der Wall, E. E.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_krv7vo9vhb1aver84g11hbokvk